Modest Tailwinds Could Blow Life into Mining Equities in 2015: Shane Nagle
Source: Brian Sylvester of The Gold Report  (2/23/15)
Lower oil prices in concert with currency devaluation versus the U.S. greenback in established mining jurisdictions like Mexico and Canada could translate into sustainably increased operating margins at some operations and a rally in precious and base metals equities, says Shane Nagle, mining analyst with Toronto-based National Bank Financial. In this interview with The Gold Report, Nagle selects some promising precious metals stories, along with his two top picks in the base metals space. More >

ROTH Capital's John White Pumps the Permian for Profit
Source: Tom Armistead of The Energy Report  (2/19/15)
John White has initiated coverage on several small-cap exploration and production companies in the Permian Basin, the latest of the major basins to turn in a big way from vertical oil and gas wells to horizontal fractured wells. In this interview with The Energy Report, the ROTH Capital Partners senior research analyst names five Permian players on his list of favorites. More >

CEL-SCI Corp.'s Novel Immunotherapies Set Sights on Cancer, Autoimmune Disorders and Infectious Diseases
Source: Dan Levy of The Life Sciences Report  (2/19/15)
Control and manipulation of the immune system is the underlying basis behind vaccinations in the fight against dangerous infectious diseases, but using immunotherapies to treat cancers and autoimmune disorders has been limited. That paradigm is changing, and CEL-SCI Corp. is among the companies poised to bring immunotherapy into these disease spaces. In this interview with The Life Sciences Report, Geert Kersten, CEL-SCI's CEO, describes how his company's Multikine and L.E.A.P.S. platforms can be deployed, and how investors can turn an immunotherapeutic win into profit. More >

Alphastox's Moshevich Defines the One Thing Strong Energy Juniors Share
Source: Peter Byrne of The Energy Report  (2/19/15)
The implosion of oil and gas prices will flush out oil and gas exploration juniors with weak balance sheets and too much debt, says Etienne Moshevich, editor of Alphastox.com. The small-cap companies left standing, however, are poised to soar once the market begins to accelerate. In this interview with The Energy Report, Moshevich touts the benefits of motivated management teams and solid balance sheets for all companies in the energy sector, and singles out seven oil and gas juniors, plus a pair of uranium picks, with outstanding prospects come the turnaround. More >

Immuno-Oncology Promises Continued Wealth and Health: LifeTech Capital's Stephen Dunn
Source: Staff of The Life Sciences Report  (2/19/15)
Immuno-oncology—disabling cancer's defenses so that a patient's own immune system can seek it out and destroy it—took center stage in the drug development world in 2014. Stephen Dunn of LifeTech Capital believes that preeminence will continue in 2015, bolstered by new drug approvals, new targets and new combination immunotherapies that increase potency. In this interview with The Life Sciences Report, Dunn outlines how companies large and small are leveraging these therapies, and where investors should look for opportunity in the sector. More >

Mind-Blowing: China Consumes More Gold Than the World Produces
Source: Frank Holmes, U.S. Global Investors  (2/19/15)
"What's not so well-known is that China's supply of the precious metal per capita is actually low compared to neighboring Asian countries such as Taiwan and Singapore." More >

The Resource Maven Tells Investors How to Take Advantage of a Rising Happiness Index
Source: Kevin Michael Grace of The Gold Report  (2/18/15)
The bottom is in, says Gwen Preston, founder of the Resource Maven, but the next bull market in gold hasn't yet arrived. In this interview with the The Gold Report, she argues that investors should concentrate on finding likely takeover targets and explains that these companies are often distinguished by strong investor and institutional backing. She identifies four such companies, as well as highlighting two exciting explorers and the one gold major best positioned for a robust recovery. More >

The Real Breakeven Price of Oil Is Not What You Think
Source: Keith Schaefer, Oil and Gas Investments Bulletin  (2/18/15)
"In a zero interest rate policy environment, Wall Street debt syndicates will set the oil price, not the Saudis or the U.S. producers." More >

Jeb Handwerger: A Surge in M&As Proves that Gold Is Back
Source: Kevin Michael Grace of The Mining Report  (2/17/15)
Gold stocks have been trading at huge discounts for years, but even rock-bottom prices couldn't entice takeover bids until the market hit bottom. The bottom is now here, says Jeb Handwerger, founder of GoldStockTrades.com, and M&As are off to a roaring start this year. In this interview with The Mining Report, Handwerger predicts a new record gold price within 18 months, and presents a host of gold and other metal equities poised to take off in 2015. More >

Global Insecurity Is Good for Gold, Says Mike Niehuser
Source: Kevin Michael Grace of The Gold Report  (2/16/15)
International anxiety may be good for gold prices, as gold continues to have a place as a store of value in uncertain times, says Mike Niehuser of Scarsdale Securities. Lower energy prices and a stronger dollar may provide relief for precious metal miners, especially explorers and miners working outside the United States. Management teams that have been forced to adapt to survive should do well in an upturn, and in this interview with The Gold Report, Niehuser discusses a handful of companies that fit the bill, including one in renewable energy. More >

Low Oil Prices Are an Act of Economic Warfare: Veteran Investor Bob Moriarty
Source: Karen Roche, The Energy Report  (2/12/15)
This is a wonderful time to have cash and be in the oil business, according to Bob Moriarty of 321energy.com. That's because savvy juniors can go shopping for assets being sold as "uneconomic" when oil is $40–50/barrel. But the low price won't last, he tells The Energy Report, predicting much higher oil within the year. And while that increase will cause oil stocks to rise in tandem, Moriarty reminds investors that it still pays to be selective. More >

Bloom Burton's David Martin Zeroes In on Under-the-Radar Biotech
Source: George S. Mack of The Life Sciences Report  (2/12/15)
Biotechnology indices have been on a rapid ascent for three years, and 2015 appears to be off to the races as well. Bloom Burton & Co.'s David Martin has taken his seat in the grandstands, betting on specialty pharma and biotech companies based in Canada, where resource stocks have absorbed so much investment capital that many healthcare names have remained hidden and undervalued. In this interview with The Life Sciences Report, Martin highlights a group of companies with superior growth prospects and room to run. More >

Avoid Dodos and Find Gold and Silver Miners that Can Soar, Says Raymond James' Chris Thompson
Source: Brian Sylvester of The Gold Report  (2/11/15)
Chris Thompson, mining analyst with Raymond James, is looking for companies that can continue to deliver real growth and shareholder upside—companies that can "fly"—regardless of metal prices. The high-flyers with upside, Thompson says, have good management, strong cash flow at current metal prices, organic growth potential and are undervalued relative to their peers offering those same attributes. In this interview with The Gold Report, Thompson offers some precious metal names that could soar. More >

Hedge Against Short-Term Cycles with Lithium: Daniela Desormeaux
Source: Tom Armistead of The Mining Report  (2/10/15)
Lithium is for long-term investors, says Daniela Desormeaux, founder of signumBOX. Its future will be driven by soaring demand for batteries for electric vehicles and electronics. In this interview with The Mining Report, Desormeaux notes that lithium is less dependent on short-term economic cycles than commodities like oil and copper, and says demand for lithium will grow faster than the global economy. The entry of new players to the market is making what was an oligopoly more diverse and competitive, and she highlights some of the exciting projects being developed. More >

Blackbird's Garth Braun: Leveraging Leadership, Foresight and Natural Gas Liquids
Source: George S. Mack of The Energy Report  (2/10/15)
When an energy company has grown its share price more than 400% against strong headwinds in one year, that's an attention-getter. The formula, as always, is to get the right management, after which value will be created and growth will follow. CEO Garth Braun of Blackbird Energy Inc. has made sweet lemonade out of a sour market in fossil fuels. In this interview with The Energy Report, Braun describes his business model and talks about his management and leadership style. More >

Gold Stocks: This Bear Phase Isn't Over Yet
Source: Bob Kirtley, Gold-Prices.biz  (2/10/15)
"The precious metals sector is as volatile as they come and this current phase is particularly treacherous." More >

The Companies Bob Moriarty Loves for the Long Term
Source: Karen Roche of The Gold Report  (2/9/15)
The rapid and massive response when the Swiss unpegged the franc from the euro will ripple across the hedge fund, brokerage and financial systems. It also will infect other currencies, according to Bob Moriarty of 321gold.com. Gold, he believes, will be the last man standing. In this interview, he tells The Gold Report where he is looking for love among midtier gold and silver stocks and explains why he has no love for overpaid CEOs. More >

Capture Growth with Baskets of Biotechs: LifeSci Advisors' Andrew McDonald
Source: George S. Mack of The Life Sciences Report  (2/5/15)
Andrew McDonald believes investors fundamentally underestimate the risk of investing in companies with drugs in development. To address the inherent hazards, McDonald cofounded LifeSci Advisors, which created the BioShares Biotechnology Clinical Trials and BioShares Biotechnology Products exchange-traded funds to limit risk. In this interview with The Life Sciences Report, McDonald describes how funds can be designed to grow on product sales and data generated via milestones in clinical development, and also names four companies he's included in the two portfolios. More >

Raymond James Analyst's Four Top Picks for the Coming Uranium Upswing
Source: Tom Armistead of The Energy Report  (2/5/15)
Uranium spot prices have shown more life recently, says David Sadowski, mining equity research analyst at Raymond James, and he expects upward pressure to continue as utilities resume buying to meet future needs. In this interview, he tells The Energy Report the time is ripe to invest in uranium company stocks. In addition to his four top picks in the space, Sadowski identifies other companies whose takeout potential will be enhanced by the rising value of their properties, including one he thinks the market has undervalued. More >

Changing of the Guard at FDA: Is Califf the Next Commissioner?
Source: Damian Garde, FierceBiotech   (2/5/15)
"Under Margaret Hamburg's watch, the FDA instituted a slew of programs designed to speed up the review process for new drugs, and 2014 saw the agency approve a 20-year-record 51 novel therapies." More >

Buy on the Biotech Dip
Source: Greg Guenthner, The Daily Reckoning  (2/5/15)
"Biotechs are still on the rampage. Feeble market in January? Biotechs don't care. They just kept bulldozing forward. In fact, biotechs were some of the only stocks popping to start the year." More >

What the Aden Sisters Are Watching Before Jumping Back into Natural Resources
Source: JT Long of The Gold Report  (2/4/15)
Technically, gold should be under $1,140 per ounce, but instead it is rising with the strong dollar. In this interview with The Gold Report, Pamela and Mary Anne Aden, authors of The Aden Forecast, see value in gold and silver and share their four favorite vehicles for gaining exposure to the upside in natural resources that is coming on the heels of a volatile currency upset. More >

The Diabetes Economy: Miraculins Scouts for Worldwide Markets
Source: Taylor Thoen, BTV/The Life Sciences Report   (2/4/15)
While other diseases catch headlines and media attention, diabetes has crept quietly into a full-blown, worldwide pandemic. With the Scout DS^®, Winnipeg-based Miraculins Inc. is on the leading edge of medical innovation with the world's first noninvasive retail screening test for diabetes. In this interview with The Life Sciences Report, Miraculins President and CEO Christopher Moreau explains how the company is poised to expand into multiple markets to meet a desperate need for diabetes screening in North America and around the world. More >

Stefan Ioannou: Bottom-Fishing Opportunities in Base Metals, Especially Zinc
Source: Brian Sylvester of The Mining Report  (2/3/15)
Copper is off to a rough start in 2015 and while other base metals have also shown price weakness, zinc could finish 2015 strong, says Stefan Ioannou, mining analyst with Haywood Securities. He estimates that over the previous two years about 12% of global zinc production ceased and more will end soon, ultimately leading to a run in the zinc price in late 2015 and into 2016. In this interview with The Mining Report, Ioannou discusses his top zinc pick and some high-grade, low-cost copper producers with zinc production profiles. More >

Contrarian Economist John Mauldin: How to Position Your Portfolio to Win in the Currency Wars
Source: JT Long of The Gold Report  (2/2/15)
Collateral damage from the currency wars in Europe, Japan and Russia could topple political leaders, put banks out of business and homeowners on the street. It can also play havoc with a portfolio. That is why The Gold Report called Mauldin Economics founder John Mauldin to ask how can readers protect themselves and perhaps even prosper. More >